Management of Early Breast Cancer at an Australian Cancer Centre During the Early Phase of COVID-19 Pandemic

Background: This study aimed to prospectively record changes to treatment for early breast cancer patients during the first wave of the COVID-19 pandemic in Australia. The purpose was to assess the impact on breast cancer outcomes and to determine the need for any mitigative actions. Methods: T...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Elissa J Zhang, Kirsty Stuart, Rina Hui, Rhiannon Mellor, Wei Wang, Verity Ahern, Farid Meybodi, James French, Elisabeth Elder, Meagan Brennan
Formato:	article
Lenguaje:	EN
Publicado:	Kaviani Breast Disease Institute 2021
Materias:	Early breast cancer, Cancer management, COVID-19 Breast cancer Coronavirus Surgery Radiotherapy Chemotherapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/3b26419e6f494d3f986a28d51e225126
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3b26419e6f494d3f986a28d51e225126
record_format	dspace
spelling	oai:doaj.org-article:3b26419e6f494d3f986a28d51e2251262021-12-04T02:18:52ZManagement of Early Breast Cancer at an Australian Cancer Centre During the Early Phase of COVID-19 Pandemic10.32768/abc.202184318-3282383-0433https://doaj.org/article/3b26419e6f494d3f986a28d51e2251262021-10-01T00:00:00Zhttps://www.archbreastcancer.com/index.php/abc/article/view/443https://doaj.org/toc/2383-0433 Background: This study aimed to prospectively record changes to treatment for early breast cancer patients during the first wave of the COVID-19 pandemic in Australia. The purpose was to assess the impact on breast cancer outcomes and to determine the need for any mitigative actions. Methods: The study was conducted in the breast cancer unit of a tertiary referral hospital. Patients with early (non-metastatic) breast malignancy discussed in multidisciplinary team meetings between March and June 2020 were included. Patients were newly diagnosed, post-operative or post-neoadjuvant chemotherapy. Standard treatment was defined by Westmead Breast Cancer Institute protocols and any variations related to the pandemic were recorded. Results: In the study, 145 patients were included (median age 59 years). Pandemic-related changes to management were noted in 13 of 145 (9.0%) patients. Four patients experienced a delay to cancer treatments, four were not offered reconstructive/ symmetrisation surgical procedures, three had altered radiotherapy protocols and two patients were not offered enrolment to a clinical trial. These impacts affected the groups presenting with new cancers (n=7/86, 8.1%), post-operative cases (n=4/25, 16.0%) and post-neoadjuvant chemotherapy cases presenting for surgical planning (n=2/34, 5.9%). Conclusion: Most patients (91.0%) received standard treatment during the first wave of the pandemic. The minor variations from institutional protocols observed in this study are unlikely to affect local control or survival in this patient cohort, but close follow-up is required. Quality of life may have been affected for four patients who had downgraded or delayed reconstructive procedures. Elissa J ZhangKirsty StuartRina HuiRhiannon MellorWei WangVerity AhernFarid MeybodiJames FrenchElisabeth ElderMeagan BrennanKaviani Breast Disease InstitutearticleEarly breast cancer, Cancer management, COVID-19Breast cancerCoronavirusSurgeryRadiotherapyChemotherapyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENArchives of Breast Cancer (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Early breast cancer, Cancer management, COVID-19 Breast cancer Coronavirus Surgery Radiotherapy Chemotherapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Early breast cancer, Cancer management, COVID-19 Breast cancer Coronavirus Surgery Radiotherapy Chemotherapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Elissa J Zhang Kirsty Stuart Rina Hui Rhiannon Mellor Wei Wang Verity Ahern Farid Meybodi James French Elisabeth Elder Meagan Brennan Management of Early Breast Cancer at an Australian Cancer Centre During the Early Phase of COVID-19 Pandemic
description	Background: This study aimed to prospectively record changes to treatment for early breast cancer patients during the first wave of the COVID-19 pandemic in Australia. The purpose was to assess the impact on breast cancer outcomes and to determine the need for any mitigative actions. Methods: The study was conducted in the breast cancer unit of a tertiary referral hospital. Patients with early (non-metastatic) breast malignancy discussed in multidisciplinary team meetings between March and June 2020 were included. Patients were newly diagnosed, post-operative or post-neoadjuvant chemotherapy. Standard treatment was defined by Westmead Breast Cancer Institute protocols and any variations related to the pandemic were recorded. Results: In the study, 145 patients were included (median age 59 years). Pandemic-related changes to management were noted in 13 of 145 (9.0%) patients. Four patients experienced a delay to cancer treatments, four were not offered reconstructive/ symmetrisation surgical procedures, three had altered radiotherapy protocols and two patients were not offered enrolment to a clinical trial. These impacts affected the groups presenting with new cancers (n=7/86, 8.1%), post-operative cases (n=4/25, 16.0%) and post-neoadjuvant chemotherapy cases presenting for surgical planning (n=2/34, 5.9%). Conclusion: Most patients (91.0%) received standard treatment during the first wave of the pandemic. The minor variations from institutional protocols observed in this study are unlikely to affect local control or survival in this patient cohort, but close follow-up is required. Quality of life may have been affected for four patients who had downgraded or delayed reconstructive procedures.
format	article
author	Elissa J Zhang Kirsty Stuart Rina Hui Rhiannon Mellor Wei Wang Verity Ahern Farid Meybodi James French Elisabeth Elder Meagan Brennan
author_facet	Elissa J Zhang Kirsty Stuart Rina Hui Rhiannon Mellor Wei Wang Verity Ahern Farid Meybodi James French Elisabeth Elder Meagan Brennan
author_sort	Elissa J Zhang
title	Management of Early Breast Cancer at an Australian Cancer Centre During the Early Phase of COVID-19 Pandemic
title_short	Management of Early Breast Cancer at an Australian Cancer Centre During the Early Phase of COVID-19 Pandemic
title_full	Management of Early Breast Cancer at an Australian Cancer Centre During the Early Phase of COVID-19 Pandemic
title_fullStr	Management of Early Breast Cancer at an Australian Cancer Centre During the Early Phase of COVID-19 Pandemic
title_full_unstemmed	Management of Early Breast Cancer at an Australian Cancer Centre During the Early Phase of COVID-19 Pandemic
title_sort	management of early breast cancer at an australian cancer centre during the early phase of covid-19 pandemic
publisher	Kaviani Breast Disease Institute
publishDate	2021
url	https://doaj.org/article/3b26419e6f494d3f986a28d51e225126
work_keys_str_mv	AT elissajzhang managementofearlybreastcanceratanaustraliancancercentreduringtheearlyphaseofcovid19pandemic AT kirstystuart managementofearlybreastcanceratanaustraliancancercentreduringtheearlyphaseofcovid19pandemic AT rinahui managementofearlybreastcanceratanaustraliancancercentreduringtheearlyphaseofcovid19pandemic AT rhiannonmellor managementofearlybreastcanceratanaustraliancancercentreduringtheearlyphaseofcovid19pandemic AT weiwang managementofearlybreastcanceratanaustraliancancercentreduringtheearlyphaseofcovid19pandemic AT verityahern managementofearlybreastcanceratanaustraliancancercentreduringtheearlyphaseofcovid19pandemic AT faridmeybodi managementofearlybreastcanceratanaustraliancancercentreduringtheearlyphaseofcovid19pandemic AT jamesfrench managementofearlybreastcanceratanaustraliancancercentreduringtheearlyphaseofcovid19pandemic AT elisabethelder managementofearlybreastcanceratanaustraliancancercentreduringtheearlyphaseofcovid19pandemic AT meaganbrennan managementofearlybreastcanceratanaustraliancancercentreduringtheearlyphaseofcovid19pandemic
_version_	1718373025114488832

Management of Early Breast Cancer at an Australian Cancer Centre During the Early Phase of COVID-19 Pandemic

Ejemplares similares